VF
AMED

Virtu Financial’s Amedisys AMED Stock Holding History

Virtu Financial’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,736
Closed -$269K – 1433
2025
Q2 		$269K Sell
2,736
-595
-18% -$56.3K 0.01% 793
2025
Q1 		$309K Buy
+3,331
New +$307K 0.02% 660
2023
Q3 		– Sell
-2,745
Closed -$251K – 1259
2023
Q2 		$251K Buy
+2,745
New +$225K 0.02% 696
2022
Q4 		– Sell
-4,245
Closed -$411K – 1555
2022
Q3 		$411K Buy
4,245
+326
+8% +$38.9K 0.04% 489
2022
Q2 		$412K Buy
+3,919
New +$501K 0.04% 443
2021
Q4 		– Sell
-1,738
Closed -$259K – 1668
2021
Q3 		$259K Buy
+1,738
New +$361K 0.02% 785
2021
Q1 		– Sell
-688
Closed -$202K – 1563
2020
Q4 		$202K Sell
688
-287
-29% -$73.6K 0.02% 855
2020
Q3 		$231K Sell
975
-2,377
-71% -$540K 0.04% 536
2020
Q2 		$666K Buy
+3,352
New +$625K 0.08% 284
2019
Q4 		$442K Buy
+2,649
New +$394K 0.04% 475

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Virtu Financial's AMED Position: Q3 2025 in Review

Virtu Financial sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2,736 shares — an estimated $269K sold.

Virtu Financial first reported a position in AMED in Q4 2019 and held it in 10 quarters. The position peaked at $666K in Q2 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Virtu Financial reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Virtu Financial sold 2,736 Amedisys shares in Q3 2025, an estimated $269K.
  • Virtu Financial first reported a position in Amedisys in Q4 2019 and held it in 10 quarters.
  • Virtu Financial's Amedisys position peaked at $666K in Q2 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.